Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
EARLY_PHASE1
90 participants
INTERVENTIONAL
2020-02-25
2026-02-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Repetitive Acute Intermittent Hypoxia for Spinal Cord Repair
NCT03433599
Hypoxia Pathways for Early Recovery After Spinal Cord Injury
NCT07002437
Study Effects of Intermittent Hypoxia on Restoring Hand Function Following SCI
NCT01272336
Daily Intermittent Hypoxia and Task-Specific Upper Limb Training in Persons With Chronic Incomplete SCI
NCT03262766
Motor Plasticity, Intermittent Hypoxia and Sleep Apnea
NCT04017767
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Specific Aim 1, using an adult rat model of chronic contusive cSCI, the investigators will investigate the effects of rAIH frequency and dose on rAIH/training-mediated functional recovery of the impaired forelimb. Also, the investigators will combine rAIH/training with N-methyl-D-aspartate receptor (NMDA)-mediated synaptic plasticity through D-cycloserine treatment and study the effects on recovery of forelimb function. Immunocytochemistry with imaging techniques will be used to assess structural neuronal plasticity in the CST after rAIH/training. In Specific Aim 2, in people with chronic incomplete cSCI, guided by the findings in Specific Aim 1, the investigators will study the effects of rAIH frequency and concurrent D-cycloserine treatment on rAIH/training-mediated upper limb function recovery. The investigators will comprehensively analyze the effects of rAIH on the strength of electrophysiological and functional aftereffects in the upper limb.
The proposed research will provide new knowledge on rAIH/training-mediated functional and anatomical aftereffects (Specific Aim 1), which will be used to develop effective rAIH/training protocols for people with contusive, functionally incomplete, cSCI (Specific Aim 2). The data from the investigators' experiments may lead to clinically applicable approaches that improve arm and hand function recovery after chronic contusive cSCI, which would positively impact the quality of life of Veterans with cSCI. The relevance of this proposal is emphasized by the limited efficacy of current strategies to improve upper limb function after cSCI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hypoxia plus training
combined hypoxia treatment with exercise training
hypoxia
intermittent cycles of normoxia-hypoxia
exercise training
bimanual massed practice training
sham hypoxia plus training
combined sham hypoxia treatment with exercise training
sham hypoxia
intermittent cycles of sham hypoxia
exercise training
bimanual massed practice training
hypoxia plus training plus NMDA agonist
combined hypoxia treatment with exercise training and with NMDA agonist treatment
hypoxia
intermittent cycles of normoxia-hypoxia
D-cycloserine
NMDA agonist treatment
exercise training
bimanual massed practice training
hypoxia plus training plus sham NMDA agonist
combined hypoxia treatment with exercise training and with sham NMDA agonist treatment
hypoxia
intermittent cycles of normoxia-hypoxia
sham-NMDA agonist
sham-NMDA agonist treatment
exercise training
bimanual massed practice training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hypoxia
intermittent cycles of normoxia-hypoxia
sham hypoxia
intermittent cycles of sham hypoxia
D-cycloserine
NMDA agonist treatment
sham-NMDA agonist
sham-NMDA agonist treatment
exercise training
bimanual massed practice training
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic cSCI (1 yr of injury)
* Cervical injury at C8 or above
* Sensory function: impaired (score of 1) but not absent (score of 0) or intact (score of 2) innervations in dermatomes C6, C7 and C8 during light touch and pin prick stimulus using the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) sensory scores
* Motor function: Able to grasp small objects with one hand and able to perform a visible precision grasp between the index finger and thumb
* Motor scores ISNCSCI: 1 to 4 but not 5 on finger flexors and finger abductors on the hand tested.
* These criteria were selected to ensure that hand impairment will not interfere with the ability to perform training and proposed tests
* Male and females (18-80 years)
* Right handed
* Able to complete precision and power grips
Exclusion Criteria
* Any debilitating disease prior to the SCI that caused exercise intolerance
* Premorbid, ongoing major depression or psychosis, altered cognitive status
* History of head injury or stroke
* Metal plate in skull
* History of seizures
* Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs
* chlorpromazine
* clozapine
* or tricyclic antidepressants
* Pregnant females
* Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease as spinal stenosis, spina bifida or herniated cervical disk
* resting heart rate \> 120 bpm
* resting systolic blood pressure \>180 mmHg
* resting diastolic blood pressure \>100 mmHg
* self-reported history of unstable angina or myocardial infarction within the previous month
* resting SpO2 \> or equal to 95%
* cardiopulmonary complications such as COPD
* Same as for SCI individuals
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Oudega, PhD
Role: PRINCIPAL_INVESTIGATOR
Edward Hines Jr. VA Hospital, Hines, IL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Edward Hines Jr. VA Hospital, Hines, IL
Hines, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B2848-R
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.